Literature DB >> 25183934

Platelet rich fibrin (Prf) and β-tricalcium phosphate with coronally advanced flap for the management of grade-II furcation defect.

Jain Sambhav1, Rai Rohit1, Mohan Ranjana1, Mehrotra Shalabh1.   

Abstract

BACKGROUND: Multirooted teeth offer unique and challenging problems due to the furcation area, creates situations in which routine periodontal procedures are somewhat limited and special procedures are generally required. CASE DETAIL: The present case was showing the management of grade II furcation defect by platelet rich fibrin (PRF) and β-Tricalcium phosphate with coronally advanced flap.
CONCLUSION: Platelet rich fibrin and β-Tricalcium phosphate with coronally advanced flap have been shown to be a promising and successful approach for the treatment of furcation defect. Its gaining clinical attachment significantly manages both the gingival recession and furcation involvement simultaneously.

Entities:  

Keywords:  Coronally Advanced Flap; Furcation Involvement; Platelet Rich Fibrin; β-Tricalcium Phosphate

Mesh:

Substances:

Year:  2014        PMID: 25183934      PMCID: PMC4141231          DOI: 10.4314/ejhs.v24i3.11

Source DB:  PubMed          Journal:  Ethiop J Health Sci        ISSN: 1029-1857


Introduction

Periodontal tissue is destroyed in the course of Periodontitis by disproportionate immunologic responses to a triggering agent, such as bacteria in biofilm (1). It has been reported that molars with furcation involved caused by periodontitis, have a higher rate of periodontal breakdown and respond less favorably to periodontal therapy than molars without furcation involvement or single-rooted teeth (2–4). Multirooted teeth offer unique and challenging problems for the periodontist. The furcation area, because of the interrelationships between the size and shape of the teeth, the roots and their alveolar housing, and the varied nature and pattern of periodontal destruction create situations in which routine periodontal procedures are somewhat limited and special procedures are generally required. It has been shown that the best chance for success lies in early recognition and treatment of furcation involvement (5). Grade II furcation is any involvement of the interradicular bone without a through-and-through ability to probe (6). Various materials have been used to resolve furcation defect including autografts (7–11), demineralised freeze-dried bone allografts (DFDBAs) (12–13), bovine-derived xenografts, barrier membranes and combinations of membranes and bone grafts. Although these regenerative materials are being used today, the introduction of biomimetic agents such as enamel matrix derivatives (13), platelet rich plasma (PRP) (14), platelet-derived growth factor and bone morphogenetic proteins (13) have shown better outcomes in furcation treatment. Platelet-rich fibrin (PRF) developed in France by Choukroun et al (14) is a second generation platelet concentrate. Its advantages over the better known platelet-rich plasma (PRP) include ease of preparation/application, minimal expense and lack of biochemical modification (no bovine thrombin or anticoagulant is required). PRF is a strictly autologous fibrin matrix containing a large quantity of platelet and leukocyte cytokines (13–18). Resorbable tissue replacement (R.T.R) is a biocompatible synthetic alloplast material of the highest purity. RTR granules have a β-Tricalcium phosphate crystalline (β TCP) structure. It is extremely hydrophilic, so it is drawn into the surgical site and can be easily contoured to fill any bony void. This makes RTR ideal for the treatment of periodontal defects, ridge augmentations, and extraction socket therapy (post-extraction ridge preservation). The coronally advanced flap is a simple pedicle flap that can be utilized for root coverage, and does not require graft harvesting. A potential limitation of the coronally advanced flap is the limited gain in the apico-coronal dimension of the keratinized tissue which is an important parameter in preventing the recurrence of gingival recession (19).This case report shows the effectiveness of PRF along with bone graft to manage grade-II furction defect.

Case Report

A 45 year old female reported to the Department Of Periodontology, Teerthankar Mahaveer Dental College and Research Centre with a chief complaint of severe sensitivity, bleeding and food lodgment in the lower left back region since last 3 months. On clinical and radiographic examination, advanced grade-II buccal furcation involvement and recession with 36 were diagnosed. There was no attachment loss on lingual surface of 36 (Figure 1). Ethical clearance was obtained from the ethical board of the Teerthanker Mahaveer University. Informed consent was also secured from the patient for the procedure and use of her record for publication.
Figure 1

(a) 9 mm loss of horizontal clinical attachment when measure with Naber's probe, (b) 7mm loss of Bucally vertical attachment when measured with William's probe, (c) Radiographic image

(a) 9 mm loss of horizontal clinical attachment when measure with Naber's probe, (b) 7mm loss of Bucally vertical attachment when measured with William's probe, (c) Radiographic image

Pre-Surgical Therapy

That patient underwent Scaling and Root Planning by ultrasonic dental unit (Denstply Cavitron Bobcat Pro) and Gracey curettes (Hu-Friedy) under local anaesthesia. The patient received special training on brushing her teeth twice daily using the modified Bass technique and flossing. Patient's oral hygiene was acceptable before the surgery. For the preparation of platelet rich fibrin centrifugation machine, 5ml syringe and 9ml blood collection tubes were used. Five milliliter blood was collected from the same patient. Then, the blood was drawn into the tube without anticoagulant. The blood was transferred to centrifugation machine within 1–2 minutes after collection and it centrifuged for 15 minutes at 3000rpm. Absence of anticoagulant allows activating the majority of the platelets contained in the sample which triggers a coagulation cascade. Fibrinogen initially concentrates in the upper part of the tube; until the effect of the circulating thrombin transforms it into a fibrin network (Figure 2 & 3).The PRF was collected from centrifuge tube with tweezer and placed on a sterile gauze piece.
Figure 2

(a) Blood drawn into the tube without anticoagulant, (b) Blood centrifuged for 15 min at 3000rpm, (c) Pliers inserted into the tube to gently grab the fibrin clot with attached RBC's, (d) platelet rich fibrin

(a) Blood drawn into the tube without anticoagulant, (b) Blood centrifuged for 15 min at 3000rpm, (c) Pliers inserted into the tube to gently grab the fibrin clot with attached RBC's, (d) platelet rich fibrin Different layer in centrifuged blood

Surgical Procedure

The surgical site was isolated and anaesthetized with 2% xylocaine hydrochloride with adrenaline (1:200000). Two vertical incisions were made, one on the mesial line angle of the second molar and the other on the distal line angle of the second pre-molar beyond the mucogingival junction. Crevicular incision was made from the mesial vertical incision to the distal vertical incision. The full thickness flap was then raised beyond the mucogingival junction.The furcation area was debrided thoroughly, and granulation tissue was removed through scaling and root planning. After scaling and root planning R.T.R granules were placed in the furcation defect area. After the RTR granules were placed, PRF membrane was placed to cover the site and the osseous graft (Figure 4). The patient was evaluated at 1,3, 6 and 9 months with a positive result when grade-II furcation defect was treated with PRF and beta-Tricalcium phosphate.
Figure 4

(a) Full thickness flap raised, (b) R.T.R granules placed in the furcation defect area, (c) PRF membrane placed to cover the site and the osseous graft, (d) 1 month post-oprative

(a) Full thickness flap raised, (b) R.T.R granules placed in the furcation defect area, (c) PRF membrane placed to cover the site and the osseous graft, (d) 1 month post-oprative

Discussion

Platelet-rich fibrin (PRF), developed in France by Choukroun et al (14), is a second generation platelet concentrate widely used to accelerate soft and hard tissue healing. Although PRF has been used for several procedures such as ridge augmentation, the furcation defect is mostly managed by bone graft and Guided Tissue Regeneration Membrane. But, very few studies have been conducted to evaluate the effect of PRF in treatment of furcation defects. Although PRF has been used for several procedures such as ridge augmentation, very few studies have been conducted to evaluate the effect of PRF in treatment of furcation defects. Platelet rich fibrin and β-Tricalcium phosphate with coronally advanced flap has been shown to be a promising and successful approach for the treatment of furcation defect. Its gaining clinical attachment significantly manages both the gingival recession and furcation involvement simultaneously. This case report suggests that the combined treatment approach i.e. with PRF and beta-tricalcium phosphate was effective in treating the furcation defect. The placement of beta-tri-calcium phosphate along with platelet rich fibrin gel is still a young field in which many discoveries are yet to be made. The primary goal of the study was to manage grade-II furcation defect with the help of platelet rich fibrin and beta tricalcium phosphate which showed promising results.
  17 in total

1.  Effects of a mineralized human cancellous bone allograft in regeneration of mandibular Class II furcation defects.

Authors:  Yi-Pin Tsao; Rodrigo Neiva; Khalaf Al-Shammari; Tae-Ju Oh; Hom-Lay Wang
Journal:  J Periodontol       Date:  2006-03       Impact factor: 6.993

Review 2.  Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF).

Authors:  David M Dohan Ehrenfest; Lars Rasmusson; Tomas Albrektsson
Journal:  Trends Biotechnol       Date:  2009-01-31       Impact factor: 19.536

3.  Clinical evaluation of a modified coronally advanced flap alone or in combination with a platelet-rich fibrin membrane for the treatment of adjacent multiple gingival recessions: a 6-month study.

Authors:  Sofia Aroca; Tibor Keglevich; Bruno Barbieri; Istvan Gera; Daniel Etienne
Journal:  J Periodontol       Date:  2009-02       Impact factor: 6.993

4.  A randomized clinical trial of autologous platelet-rich plasma in the treatment of mandibular degree II furcation defects.

Authors:  Avani Rangaraju Pradeep; Sujatha Pai; Garima Garg; Prapulla Devi; Sharath Kumara Shetty
Journal:  J Clin Periodontol       Date:  2009-07       Impact factor: 8.728

5.  A randomized clinical multicentre trial comparing enamel matrix derivative and membrane treatment of buccal class II furcation involvement in mandibular molars. Part III: patient factors and treatment outcome.

Authors:  Thomas Hoffmann; Steffen Richter; Joerg Meyle; Jose R Gonzales; Bernd Heinz; Mehrdad Arjomand; Anton Sculean; Elmar Reich; Karin Jepsen; Søren Jepsen; Rolf-Hasso Boedeker
Journal:  J Clin Periodontol       Date:  2006-08       Impact factor: 8.728

Review 6.  Present status of osseous grafting procedures.

Authors:  R G Schallhorn
Journal:  J Periodontol       Date:  1977-09       Impact factor: 6.993

7.  Iliac transplants in periodontal therapy.

Authors:  R G Schallhorn; W H Hiatt; W Boyce
Journal:  J Periodontol       Date:  1970-10       Impact factor: 6.993

8.  Effect of periodontal therapy on patients maintained for 15 years or longer. A retrospective study.

Authors:  M J Goldman; I F Ross; D Goteiner
Journal:  J Periodontol       Date:  1986-06       Impact factor: 6.993

9.  Histologic evaluation of new attachment apparatus formation in humans. Part I.

Authors:  G M Bowers; B Chadroff; R Carnevale; J Mellonig; R Corio; J Emerson; M Stevens; E Romberg
Journal:  J Periodontol       Date:  1989-12       Impact factor: 6.993

10.  The effect of plaque control after scaling and root planing on the subgingival microflora in human periodontitis.

Authors:  D L Lavanchy; M Bickel; P C Baehni
Journal:  J Clin Periodontol       Date:  1987-05       Impact factor: 8.728

View more
  2 in total

Review 1.  From Blood to Regenerative Tissue: How Autologous Platelet-Rich Fibrin Can Be Combined with Other Materials to Ensure Controlled Drug and Growth Factor Release.

Authors:  Karina Egle; Ilze Salma; Arita Dubnika
Journal:  Int J Mol Sci       Date:  2021-10-26       Impact factor: 5.923

2.  Histologic, Histomorphometric, and Clinical Analysis of the Effects of Growth Factors in a Fibrin Network Used in Maxillary Sinus Augmentation.

Authors:  Ihsan Caglar Cinar; Bahattin Alper Gultekin; Alper Saglanmak; Serdar Yalcin; Vakur Olgac; Eitan Mijiritsky
Journal:  Int J Environ Res Public Health       Date:  2020-03-15       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.